Yıl 2019,
Cilt: 4 Sayı: 3, - , 31.12.2019
Sevin Coşar Ayaz
,
Hasanali Durmaz
,
Mehmet Ercüment Döğen
Kaynakça
- Thompson RJ, Taylor MA, McKie LD, Diamond T. (2006). Sinistral portal hypertension. Ulster Med J; 75(3):175–7. 2. Sakorafas GH, Sarr MG, Farley DR, Farnell MB. (2000). The significance of sinistral portal hypertension complicating chronic pancreatitis. Am J Surg; 179(2):129–33.3. Coşar Ayaz S , Durmaz HA , Döğen ME. (2019). Mide adenokarsinomlarında primer tümör ve karaciğer metastazlarının FDG PET/BT parametrelerinin karşılaştırılması. Cumhuriyet Üniv Sağ Bil Enst Derg 2019; 4(2):28-5.4. Lim JS, Yun MJ, Kim MJ, Hyung WJ, Park MS, Choi JY, Kim TS, Lee JD, Noh SH, Kim KW. (2006): CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy. Radiographics; 26(1):14–56.5. M S Madsen, T H Petersen, and H Sommer. (1986). Segmental portal hypertension. Ann Surg; 204(1):72–7.6. Wani NA, Lone TK, Shah AI, Khan AQ, Malik RA. (2011). Malignant solid pseudopapillary tumor of pancreas causing sinistral portal hypertension. Indian J Pathol Microbiol; 54(1):152–5. 7. Singhal D, Kakodkar R, Soin AS, Gupta S, Nundy S. (2006). Sinistral portal hypertension. A case report. JOP; 7(6):670–3.8. Reddy A, Sanniyasi S, George DJ, Narayanan CD. (2016). A rare case report of solid pseudopapillary tumor of the pancreas with portal hypertension. Int J Surg Case Rep; 22:35−8. 9. Hakim S, Bortman J, Orosey M, Cappell MS. (2017). Case report and systematic literature review of a novel etiology of sinistral portal hypertension presenting with UGI bleeding: Left gastric artery pseudoaneurysm compressing the splenic vein treated by embolization of the pseudoaneurysm. Medicine (Baltimore); 96(13):e6413. 10. Chang CY. (1999). Pancreatic adenocarcinoma presenting as sinistral portal hypertension: an unusual presentation of pancreatic cancer. Yale J Biol Med; 72(4):295–300.
- Sakorafas GH, Sarr MG, Farley DR, Farnell MB. (2000). The significance of sinistral portal hypertension complicating chronic pancreatitis. Am J Surg; 179(2):129–33.
- Coşar Ayaz S , Durmaz HA , Döğen ME. (2019). Mide adenokarsinomlarında primer tümör ve karaciğer metastazlarının FDG PET/BT parametrelerinin karşılaştırılması. Cumhuriyet Üniv Sağ Bil Enst Derg 2019; 4(2):28-5.
- Lim JS, Yun MJ, Kim MJ, Hyung WJ, Park MS, Choi JY, Kim TS, Lee JD, Noh SH, Kim KW. (2006): CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy. Radiographics; 26(1):14–56.
- M S Madsen, T H Petersen, and H Sommer. (1986). Segmental portal hypertension. Ann Surg; 204(1):72–7.
- Wani NA, Lone TK, Shah AI, Khan AQ, Malik RA. (2011). Malignant solid pseudopapillary tumor of pancreas causing sinistral portal hypertension. Indian J Pathol Microbiol; 54(1):152–5.
- Singhal D, Kakodkar R, Soin AS, Gupta S, Nundy S. (2006). Sinistral portal hypertension. A case report. JOP; 7(6):670–3.
- Reddy A, Sanniyasi S, George DJ, Narayanan CD. (2016). A rare case report of solid pseudopapillary tumor of the pancreas with portal hypertension. Int J Surg Case Rep; 22:35−8.
- Hakim S, Bortman J, Orosey M, Cappell MS. (2017). Case report and systematic literature review of a novel etiology of sinistral portal hypertension presenting with UGI bleeding: Left gastric artery pseudoaneurysm compressing the splenic vein treated by embolization of the pseudoaneurysm. Medicine (Baltimore); 96(13):e6413.
- Chang CY. (1999). Pancreatic adenocarcinoma presenting as sinistral portal hypertension: an unusual presentation of pancreatic cancer. Yale J Biol Med; 72(4):295–300.
MALİGN PANKREAS TÜMÖRÜNE BAĞLI SİNİSTRAL PORTAL HİPERTANSİYON TANISINDA FDG PET/BT’NİN ROLÜ: OLGU SUNUMU
Yıl 2019,
Cilt: 4 Sayı: 3, - , 31.12.2019
Sevin Coşar Ayaz
,
Hasanali Durmaz
,
Mehmet Ercüment Döğen
Öz
Tanı
amacı ile [18F]-2-floro-2-deoksi-D-glukoz (FDG) Pozitron emisyon tomografisi
(PET)/bilgisayarlı tomografi (BT) görüntüleme yapılan 67 yaşındaki erkek olguda
pankreas kuyruk kesiminde 40x32x26 mm boyutlarda, düzensiz konturlu, yoğun FDG
tutulumu gösteren (SUV maks: 6.14) primer solid malign pankreas tümörü
saptandı. Splenik ven proksimalinin sınırları kitleden ayrılamadı. Dalak
hilusunda çok sayıda splenoportal (gastrosplenik) kollateral venöz yapılar saptanmış
olup bulgular pankreastaki malign tümörün splenik ven invazyonuna/basısına
bağlı gelişmiş sinistral portal hipertansiyon
(SPH) ile uyumlu bulundu. FDG PET/BT,
malign pankreas tümörüne ikincil SPH’nin tanısında ve eşlik eden bulguların
gösterilmesinde yararlı bulunmuştur.
Kaynakça
- Thompson RJ, Taylor MA, McKie LD, Diamond T. (2006). Sinistral portal hypertension. Ulster Med J; 75(3):175–7. 2. Sakorafas GH, Sarr MG, Farley DR, Farnell MB. (2000). The significance of sinistral portal hypertension complicating chronic pancreatitis. Am J Surg; 179(2):129–33.3. Coşar Ayaz S , Durmaz HA , Döğen ME. (2019). Mide adenokarsinomlarında primer tümör ve karaciğer metastazlarının FDG PET/BT parametrelerinin karşılaştırılması. Cumhuriyet Üniv Sağ Bil Enst Derg 2019; 4(2):28-5.4. Lim JS, Yun MJ, Kim MJ, Hyung WJ, Park MS, Choi JY, Kim TS, Lee JD, Noh SH, Kim KW. (2006): CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy. Radiographics; 26(1):14–56.5. M S Madsen, T H Petersen, and H Sommer. (1986). Segmental portal hypertension. Ann Surg; 204(1):72–7.6. Wani NA, Lone TK, Shah AI, Khan AQ, Malik RA. (2011). Malignant solid pseudopapillary tumor of pancreas causing sinistral portal hypertension. Indian J Pathol Microbiol; 54(1):152–5. 7. Singhal D, Kakodkar R, Soin AS, Gupta S, Nundy S. (2006). Sinistral portal hypertension. A case report. JOP; 7(6):670–3.8. Reddy A, Sanniyasi S, George DJ, Narayanan CD. (2016). A rare case report of solid pseudopapillary tumor of the pancreas with portal hypertension. Int J Surg Case Rep; 22:35−8. 9. Hakim S, Bortman J, Orosey M, Cappell MS. (2017). Case report and systematic literature review of a novel etiology of sinistral portal hypertension presenting with UGI bleeding: Left gastric artery pseudoaneurysm compressing the splenic vein treated by embolization of the pseudoaneurysm. Medicine (Baltimore); 96(13):e6413. 10. Chang CY. (1999). Pancreatic adenocarcinoma presenting as sinistral portal hypertension: an unusual presentation of pancreatic cancer. Yale J Biol Med; 72(4):295–300.
- Sakorafas GH, Sarr MG, Farley DR, Farnell MB. (2000). The significance of sinistral portal hypertension complicating chronic pancreatitis. Am J Surg; 179(2):129–33.
- Coşar Ayaz S , Durmaz HA , Döğen ME. (2019). Mide adenokarsinomlarında primer tümör ve karaciğer metastazlarının FDG PET/BT parametrelerinin karşılaştırılması. Cumhuriyet Üniv Sağ Bil Enst Derg 2019; 4(2):28-5.
- Lim JS, Yun MJ, Kim MJ, Hyung WJ, Park MS, Choi JY, Kim TS, Lee JD, Noh SH, Kim KW. (2006): CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy. Radiographics; 26(1):14–56.
- M S Madsen, T H Petersen, and H Sommer. (1986). Segmental portal hypertension. Ann Surg; 204(1):72–7.
- Wani NA, Lone TK, Shah AI, Khan AQ, Malik RA. (2011). Malignant solid pseudopapillary tumor of pancreas causing sinistral portal hypertension. Indian J Pathol Microbiol; 54(1):152–5.
- Singhal D, Kakodkar R, Soin AS, Gupta S, Nundy S. (2006). Sinistral portal hypertension. A case report. JOP; 7(6):670–3.
- Reddy A, Sanniyasi S, George DJ, Narayanan CD. (2016). A rare case report of solid pseudopapillary tumor of the pancreas with portal hypertension. Int J Surg Case Rep; 22:35−8.
- Hakim S, Bortman J, Orosey M, Cappell MS. (2017). Case report and systematic literature review of a novel etiology of sinistral portal hypertension presenting with UGI bleeding: Left gastric artery pseudoaneurysm compressing the splenic vein treated by embolization of the pseudoaneurysm. Medicine (Baltimore); 96(13):e6413.
- Chang CY. (1999). Pancreatic adenocarcinoma presenting as sinistral portal hypertension: an unusual presentation of pancreatic cancer. Yale J Biol Med; 72(4):295–300.